Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-24 @ 7:10 PM
NCT ID:
NCT00701103
Eligibility Criteria:
Inclusion Criteria:
* Participant has metastatic or locally advanced solid tumor or multiple myeloma
* Tumor specimen has IGF-1R expression
* Participant agrees to use birth control throughout study
Exclusion Criteria:
* Participant must not be recovering from antineoplastic therapy in the last 4 weeks
* Participant has participated in a clinical trial in the last 4 weeks
* Participant has a history of heart problems such as congestive heart failure, angina, heart attack or stroke in the last 3 months
* Participant is taking growth hormone or growth hormone inhibitors
* If female, participant is pregnant or breastfeeding
* Participant is human immunodeficiency virus (HIV) positive
* Participant has a history of hepatitis B or C
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00701103
Study Brief:
Protocol Section:
NCT00701103